AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.

These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes. 

  • VASCULAR INTERVENTIONS & THERAPIES
  • VASCULAR ACCESS
  • ONCOLOGY

Changing Lives

Each day, AngioDynamics and its employees earn the trust of patients and the medical community by being a committed partner that continuously focuses on delivering safer, clinically-relevant and economically-favorable solutions that help improve patient outcomes.

Patients Are The Focus
Warren's Story

Being innovative is one thing, being part of a patient's...continuum of care, that's something that makes me get up every day and it's a powerful feeling.


Our Culture is Our Success

Become a proud member of our team

It takes a team of talented people to become one of the world’s leading providers of innovative medical devices. 

The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.

If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.

View Open Positions
04 Jan, 2019

AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results
20 Dec, 2018

AngioDynamics to Present at the J.P. Morgan Healthcare Conference

European Vascular Course

Date: 10 Mar, 2019
Time:
Location: MECC Maastricht, Netherlands

10 Dec, 2018

AngioDynamics to Report Fiscal 2019 Second Quarter Financial Results on January 4, 2019
27 Sep, 2018

AngioDynamics Reports Fiscal 2019 First Quarter Financial Results
More News & Events

New Developments

AngioDynamics Reports Fiscal 2019 Second Quarter Financial Results

Fiscal 2019 Second Quarter HighlightsNet sales of $91.5 million, an increase of 5.5% year over yearGross margin expanded 440 basis points year over year to 53.7%GAAP EPS of $0.06 per ...

Read More

Our Reach is Global

AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.

Offices in:

USA

  • Latham, NY (HQ)
  • Glens Falls, NY (Manufacturing)
  • Queensbury, NY (Manufacturing)
  • Marlborough, MA (R&D)

International

  • Oakville, CA
    (Canada Office)
  • Amsterdam, NL
    (International HQ)
  • Hong Kong, HK
    (Asia Pacific Regional Office)